144 related articles for article (PubMed ID: 28120478)
21. THE TREATMENT OF CARCINOMA IN DOGS' BLADDERS WITH CYTOTOXIC DRUGS.
BOYLAND E; KINDER CH; WILLIAMS K
Invest Urol; 1965 Mar; 2():446-52. PubMed ID: 14261785
[No Abstract] [Full Text] [Related]
22. Comparative brain and plasma pharmacokinetics and anticancer activities of chlorambucil and melphalan in the rat.
Greig NH; Sweeney DJ; Rapoport SI
Cancer Chemother Pharmacol; 1988; 21(1):1-8. PubMed ID: 3342460
[TBL] [Abstract][Full Text] [Related]
23. Treatment of 72 newly diagnosed Waldenstrom macroglobulinemia cases with oral melphalan, cyclophosphamide, and prednisone: results and cost analysis.
Annibali O; Petrucci MT; Martini V; Tirindelli MC; Levi A; Fossati C; Del Bianco P; Mandelli F; Foa R; Avvisati G
Cancer; 2005 Feb; 103(3):582-7. PubMed ID: 15611977
[TBL] [Abstract][Full Text] [Related]
24. A randomized trial comparing chlorambucil plus prednisone vs cyclophosphamide, melphalan, and prednisone in the treatment of chronic lymphocytic leukemia stages B and C.
Montserrat E; Alcalá A; Alonso C; Besalduch J; Moraleda JM; García-Conde J; Gutierrez M; Gomis F; Garijo J; Guzmán MC
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):429-32. PubMed ID: 3065738
[TBL] [Abstract][Full Text] [Related]
25. The effect of dietary amino acids on the gastrointestinal absorption of melphalan and chlorambucil.
Adair CG; McElnay JC
Cancer Chemother Pharmacol; 1987; 19(4):343-6. PubMed ID: 3594717
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and in vitro evaluation of quaternary ammonium derivatives of chlorambucil and melphalan, anticancer drugs designed for the chemotherapy of chondrosarcoma.
Giraud I; Rapp M; Maurizis JC; Madelmont JC
J Med Chem; 2002 May; 45(10):2116-9. PubMed ID: 11985479
[TBL] [Abstract][Full Text] [Related]
27. Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU.
Twentyman P; Workman P
Br J Cancer; 1982 Mar; 45(3):447-55. PubMed ID: 7073938
[TBL] [Abstract][Full Text] [Related]
28. Improper Potency and Impurities in Compounded Polidocanol.
Mann M; Munavalli GS; Amatangelo L; Morrison N
J Drugs Dermatol; 2019 Nov; 18(11):1124-1127. PubMed ID: 31741355
[TBL] [Abstract][Full Text] [Related]
29. Preserving renal function in patients with membranous nephropathy: daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide.
Reichert LJ; Huysmans FT; Assmann K; Koene RA; Wetzels JF
Ann Intern Med; 1994 Sep; 121(5):328-33. PubMed ID: 8042821
[TBL] [Abstract][Full Text] [Related]
30. Factors determining cell killing by chemotherapeutic agents in vivo. II. Melphalan, chlorambucil and nitrogen mustard.
van Putten LM; Lelieveld P
Eur J Cancer (1965); 1971 Feb; 7(1):11-6. PubMed ID: 5576726
[No Abstract] [Full Text] [Related]
31. Prescribing Bioidentical Menopausal Hormone Therapy: A Survey of Physician Views and Practices.
Dubaut JP; Dong F; Tjaden BL; Grainger DA; Duong J; Tatpati LL
J Womens Health (Larchmt); 2018 Jul; 27(7):859-866. PubMed ID: 29583064
[TBL] [Abstract][Full Text] [Related]
32. Accuracy of testosterone concentrations in compounded testosterone products.
Grober ED; Garbens A; Božović A; Kulasingam V; Fanipour M; Diamandis EP
J Sex Med; 2015 Jun; 12(6):1381-8. PubMed ID: 25963000
[TBL] [Abstract][Full Text] [Related]
33. Sensitivity of murine B- and T-lymphocytes to oxazaphosphorine and non-oxazaphosphorine nitrogen mustards.
Smith PC; Sladek NE
Biochem Pharmacol; 1985 Oct; 34(19):3459-63. PubMed ID: 3876834
[TBL] [Abstract][Full Text] [Related]
34. Effects of compounding and storage conditions on stability of pergolide mesylate.
Davis JL; Kirk LM; Davidson GS; Papich MG
J Am Vet Med Assoc; 2009 Feb; 234(3):385-9. PubMed ID: 19210262
[TBL] [Abstract][Full Text] [Related]
35. Studies on the mechanism of gastrointestinal absorption of melphalan and chlorambucil.
Adair CG; McElnay JC
Cancer Chemother Pharmacol; 1986; 17(1):95-8. PubMed ID: 3698183
[TBL] [Abstract][Full Text] [Related]
36. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
37. A Cross-sectional Online Questionnaire-based Survey About the Use of Compounded Medications in Veterinary Ophthalmology.
Andrade F; Saldanha A; Bastos JT; Montiani-Ferreira F
Int J Pharm Compd; 2024; 28(3):214-225. PubMed ID: 38768503
[TBL] [Abstract][Full Text] [Related]
38. Pharmaceutical evaluation of compounded trilostane products.
Cook AK; Nieuwoudt CD; Longhofer SL
J Am Anim Hosp Assoc; 2012; 48(4):228-33. PubMed ID: 22611212
[TBL] [Abstract][Full Text] [Related]
39. Basics of compounding: potency and stability testing.
Allen LV
Int J Pharm Compd; 2013; 17(3):220-4. PubMed ID: 24046938
[TBL] [Abstract][Full Text] [Related]
40. Multidrug resistance protein-mediated transport of chlorambucil and melphalan conjugated to glutathione.
Barnouin K; Leier I; Jedlitschky G; Pourtier-Manzanedo A; König J; Lehmann WD; Keppler D
Br J Cancer; 1998; 77(2):201-9. PubMed ID: 9460989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
